Identifying the risk of cancer-associated systemic sclerosis

Joint Bone Spine. 2023 Dec;90(6):105618. doi: 10.1016/j.jbspin.2023.105618. Epub 2023 Jul 22.

Authors

Alfredo Guillen-Del-Castillo¹, Carmen Pilar Simeón-Aznar²

Affiliations

¹ Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Electronic address: alfredo.guillen@vallhebron.cat.
² Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

PMID: 37482176
DOI: 10.1016/j.jbspin.2023.105618

No abstract available

Keywords: Antibodies; Cancer; Interstitial lung disease; Risk factors; Systemic sclerosis.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Lung
Lung Diseases, Interstitial*
Neoplasms* / epidemiology
Neoplasms* / etiology
Scleroderma, Systemic* / complications
Scleroderma, Systemic* / epidemiology